Pillstats
Capsule

Pregabalin

Pregabalin

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US12 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers2 labelers
Packages26
DEA / ScheduleCV

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.018$0.037$0.055$0.073Dec 2025Apr 2026Jul 2026
$0.055
Latest avg · Jul 22, 2026
-13%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

14K28K42K55K2025 Q12025 Q22025 Q32025 Q42026 Q1
44K
Rx · 2026 Q1
3.0M
Units dispensed
+23%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aurobindo Pharma Limitedunknown18SUPPLYING
Pfizer Manufacturing Deutschland GmbHunknown8SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.